Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
acis Arzneimittel
Oberhaching, Bavaria, Germanyacis.dermapharm.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
acis Arzneimittel develops and sells commercialized generic pharmaceuticals, with a current portfolio covering at least 34 active ingredients used to treat conditions like allergies, Parkinson's disease, and more; products are in routine clinical use.
- Therapeutic areas
- ImmunologyEndocrinologyInfectious DiseasesOtherNeurology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Partnerships
Part of Dermapharm Group, which collaborates with companies like Hasan-Dermapharm and other subsidiaries for manufacturing and distribution
Beyond the preview
Go deeper on acis Arzneimittel.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on acis Arzneimittel.